These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1026976)
1. Antagonistic effect of lithium chloride on l-dopa-induced locomotor activity in rats. Smith DF Pharmacol Res Commun; 1976 Dec; 8(6):575-9. PubMed ID: 1026976 [No Abstract] [Full Text] [Related]
2. The effect of lithium on amphetamine-induced locomotor stimulation. Berggren U; Tallstedt L; Ahlenius S; Engel J Psychopharmacology (Berl); 1978 Sep; 59(1):41-5. PubMed ID: 100811 [TBL] [Abstract][Full Text] [Related]
3. An aromatic L-amino acid decarboxylase inhibitor blocks L-dopa-induced air-stepping in neonatal rats. Arnaiz CO; Taylor LL; Stehouwer DJ; van Hartesveldt C Brain Res Dev Brain Res; 1996 Jul; 94(2):234-7. PubMed ID: 8836582 [TBL] [Abstract][Full Text] [Related]
4. The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy. Lazzara CA; Riley RR; Rane A; Andersen JK; Kim YH Brain Res; 2015 Oct; 1622():127-36. PubMed ID: 26119916 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 and D2 antagonists block L-DOPA-induced air-stepping in decerebrate neonatal rats. McCrea AE; Stehouwer DJ; Van Hartesveldt C Brain Res Dev Brain Res; 1997 May; 100(1):130-2. PubMed ID: 9174256 [TBL] [Abstract][Full Text] [Related]
6. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats. Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681 [TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 and D2 antagonists block L-dopa-elicited air-stepping in neonatal rats. Sickles AE; Stehouwer DJ; Van Hartesveldt C Brain Res Dev Brain Res; 1992 Jul; 68(1):17-22. PubMed ID: 1387836 [TBL] [Abstract][Full Text] [Related]
8. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA. Green AR; Kelly PH Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats. Heal DJ; Green AR; Bloomfield MR; Grahame-Smith DG Psychopharmacology (Berl); 1978 Apr; 57(2):193-7. PubMed ID: 26101 [TBL] [Abstract][Full Text] [Related]
10. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity. Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL Psychopharmacology (Berl); 1989; 98(4):448-52. PubMed ID: 2505284 [TBL] [Abstract][Full Text] [Related]
12. The effects of chronic lithium on the EEG and locomotor response to drug challenge in rats. Ehlers CL; Koob GF Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):133-42. PubMed ID: 4001429 [TBL] [Abstract][Full Text] [Related]
13. 3-O-methyldopa attenuates the effects of Madopar on the haloperidol-induced cataleptic behavior and the locomotor activity in the mouse. Himori N; Tanaka Y; Kurasawa M; Mishima K; Akaike N Pharmacology; 1994 Apr; 48(4):226-33. PubMed ID: 8177909 [TBL] [Abstract][Full Text] [Related]
14. Effects of tranylcypromine stereoisomers, clorgyline and deprenyl on open field activity during long term lithium administration in rats. Smith DF Psychopharmacology (Berl); 1976 Oct; 50(1):81-4. PubMed ID: 827767 [TBL] [Abstract][Full Text] [Related]
15. The effect of lithium chloride on the activity of some psychotropic drugs. Wielosz M Pol J Pharmacol Pharm; 1976; 28(2):189-98. PubMed ID: 945563 [TBL] [Abstract][Full Text] [Related]
16. Effects of lithium chloride on the activity of rats tested alone or in pairs. Syme LA; Syme GJ Psychopharmacologia; 1973 Feb; 29(1):85-9. PubMed ID: 4695209 [No Abstract] [Full Text] [Related]
17. The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats. Shimazu S; Tamashiro A; Yoneda F; Knoll J Life Sci; 2003 Feb; 72(12):1413-9. PubMed ID: 12527038 [TBL] [Abstract][Full Text] [Related]